You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 25, 2025

Drugs in MeSH Category Epithelial Sodium Channel Blockers

✉ Email this page to a colleague

« Back to Dashboard

Show entries

Subscribe to access the full database, or Try for Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

Advanz Pharma	DYRENIUM	triamterene	CAPSULE;ORAL	013174-002	Approved Prior to Jan 1, 1982	AB	RX	Yes	Yes	⤷ Try for Free	⤷ Try for Free				⤷ Try for Free
Agnitio	TRIAMTERENE	triamterene	CAPSULE;ORAL	211581-002	Aug 19, 2019	AB	RX	No	No	⤷ Try for Free	⤷ Try for Free				⤷ Try for Free
Biocon Generics	TRIAMTERENE	triamterene	CAPSULE;ORAL	214768-001	Jul 6, 2022	AB	RX	No	No	⤷ Try for Free	⤷ Try for Free				⤷ Try for Free
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Showing 1 to 3 of 3 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.